Discover a recent study that revealed that patients treated for prostate cancer, particularly with radiotherapy, have an ...

William Boruett ,86, a Cancer survivor from Eldama Ravine displays his book titled “Cancer is Not a Death Sentence” on ...

In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

expected in Q4 2024 On track for topline progression-free survival data from the phase 2b randomized controlled clinical trial of CAN-2409 in the active surveillance population with localized ...

OVERTREATMENT of prostate cancer persists among men with limited life expectancy within the Veterans Affairs (VA) health system. Despite the adoption of active surveillance, particularly for low-risk ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

About Profound Medical Corp. Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. Profound is ...

A recent study led by Cedars-Sinai researchers reveals that a growing number of older men in the U.S. with intermediate or ...

Among patients with average life expectancies of less than 10 years, the proportion who underwent treatments such as surgery ...